AHCO - AdaptHealth Corp Stock Price, Fair Value and News

9.38USD-0.05 (-0.53%)Market Closed

Market Summary

USD9.38-0.05

Market Closed

-0.53%

AHCO Alerts

1 major insider sales recently.

AHCO Stock Price

View Fullscreen

AHCO RSI Chart

AHCO Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

-1.84

Price/Sales (Trailing)

0.39

EV/EBITDA

-15.49

Price/Free Cashflow

8.71

AHCO Price/Sales (Trailing)

AHCO Profitability

EBT Margin

-22.62%

Return on Equity

-46.48%

Return on Assets

-15.04%

Free Cashflow Yield

11.49%

AHCO Fundamentals

AHCO Revenue

Revenue (TTM)

3.2B

Rev. Growth (Yr)

9.99%

Rev. Growth (Qtr)

6.74%

AHCO Earnings

Earnings (TTM)

-677.9M

Earnings Growth (Yr)

-7.3K%

Earnings Growth (Qtr)

43.73%

Breaking Down AHCO Revenue

Last 7 days

-6.7%

Last 30 days

-10.7%

Last 90 days

36.5%

Trailing 12 Months

-21.2%

How does AHCO drawdown profile look like?

AHCO Financial Health

Current Ratio

1.21

Debt/Equity

1.44

Debt/Cashflow

0.23

AHCO Investor Care

Shares Dilution (1Y)

1.23%

Diluted EPS (TTM)

-5.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	3.0B	3.1B	3.1B	3.2B
2022	2.7B	2.8B	2.9B	3.0B
2021	1.3B	1.7B	2.1B	2.5B
2020	601.6M	709.5M	857.5M	1.1B
2019	391.4M	437.5M	483.6M	529.6M
2018	0	0	0	345.3M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of AdaptHealth Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 18, 2024	clemens jason a	acquired	-	-	128,380	chief financial officer
Mar 12, 2024	flynn james e	sold	-1,229,490	10.7	-114,906	-
Mar 11, 2024	flynn james e	sold	-2,012,560	11.0212	-182,607	-
Mar 08, 2024	flynn james e	sold	-573,652	10.9294	-52,487	-
Mar 02, 2024	barasch richard a	acquired	-	-	21,206	interim ceo
Feb 29, 2024	barasch richard a	sold (taxes)	-91,906	10.23	-8,984	interim ceo
Feb 05, 2024	prast albert a.	acquired	-	-	71,339	chief technology officer
Feb 05, 2024	parnes josh	acquired	-	-	231,853	president
Feb 05, 2024	bush jonathan b	acquired	-	-	57,072	general counsel
Feb 05, 2024	clemens jason a	acquired	-	-	139,112	chief financial officer

Which funds bought or sold AHCO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	Fiduciary Alliance LLC	unchanged	-	162,660	465,931	0.08%
Apr 16, 2024	SummerHaven Investment Management, LLC	added	2.53	247,037	646,194	0.41%
Apr 15, 2024	Counterpoint Mutual Funds LLC	reduced	-59.84	-77,663	134,563	0.03%
Apr 12, 2024	HARBOR INVESTMENT ADVISORY, LLC	unchanged	-	9,452	25,782	-%
Apr 12, 2024	INSPIRION WEALTH ADVISORS, LLC	added	32.31	739,968	1,414,150	0.23%
Apr 09, 2024	MASSMUTUAL TRUST CO FSB/ADV	reduced	-71.79	-316	253	-%
Apr 05, 2024	GAMMA Investing LLC	added	197	23,035	29,201	0.01%
Apr 05, 2024	CWM, LLC	added	145	17,000	23,000	-%
Apr 04, 2024	MOODY NATIONAL BANK TRUST DIVISION	reduced	-0.03	265,492	724,485	0.06%
Apr 03, 2024	Versant Capital Management, Inc	added	329	5,564	6,526	-%

Are Funds Buying or Selling AHCO?

Are funds buying AHCO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AHCO

No. of Funds

AHCO Alerts

1 major insider sales recently.

Unveiling AdaptHealth Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	6.75%	9,199,481	SC 13G/A
Feb 12, 2024	flynn james e	8.71%	13,674,318	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 08, 2024	blackrock inc.	10.3%	14,066,565	SC 13G/A
Aug 28, 2023	everest hill group inc.	7.14%	9,721,412	SC 13D/A
Aug 11, 2023	peloton equity aerocare spv i, l.p.	1.6%	2,220,277	SC 13D/A
May 16, 2023	peloton equity aerocare spv i, l.p.	3.3%	4,460,555	SC 13D/A
Feb 10, 2023	flynn james e	4.9%	7,693,292	SC 13G/A
Feb 09, 2023	vanguard group inc	6.09%	8,211,817	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G

Recent SEC filings of AdaptHealth Corp

View All Filings

Date Filed	Form Type	Document
Apr 17, 2024	8-K	Current Report
Apr 12, 2024	PRE 14A	PRE 14A
Apr 08, 2024	5	Insider Trading
Mar 20, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 08, 2024	3	Insider Trading
Mar 04, 2024	144	Notice of Insider Sale Intent
Mar 04, 2024	4	Insider Trading
Mar 04, 2024	8-K	Current Report
Feb 27, 2024	10-K	Annual Report

Peers (Alternatives to AdaptHealth Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.6B	40.1B	-6.98%	-6.26%	31.91	4.55	-8.12%	-17.45%
BDX	67.4B	19.5B	-2.95%	-9.93%	53.63	3.46	4.02%	-22.04%
ALGN	22.6B	3.9B	-4.96%	-15.40%	50.88	5.86	3.42%	23.09%
BAX	20.1B	14.8B	-5.44%	-9.06%	7.58	1.36	2.12%	209.17%
MID-CAP
ATR	9.2B	3.5B	-0.25%	17.23%	32.29	2.63	4.97%	18.89%
HSIC	9.0B	12.3B	-5.97%	-15.68%	21.61	0.73	-2.44%	-22.68%
BIO	8.2B	2.7B	-16.50%	-42.23%	-12.88	3.07	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.09%	-25.03%	-46.91	1.59	1.10%	85.84%
AXNX	3.4B	366.4M	-2.40%	13.34%	-563.48	9.33	33.86%	89.83%
PDCO	2.3B	6.6B	-5.10%	-3.56%	11.8	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.2B	3.2B	-10.67%	-21.18%	-1.84	0.39	7.73%	-1066.14%
ANIK	378.4M	166.7M	0.43%	-6.80%	-4.58	2.27	6.67%	-456.34%
ANGO	245.1M	324.0M	10.27%	-31.54%	-1.27	0.76	-3.19%	-337.41%
APYX	47.5M	52.3M	-23.89%	-53.56%	-2.54	0.91	17.61%	19.28%
AEMD	3.7M	3.7M	-12.80%	240.48%	-0.31	1	5.77%	8.23%

AdaptHealth Corp News

Latest updates

AdaptHealth Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	6.7%	858	804	793	745	780	756	728	706	702	653	617	482	348	284	232	191	150	136	124	119	-
Costs and Expenses	-14.9%	1,076	1,265	739	718	754	704	668	655	644	578	552	467	328	271	217	183	149	128	109	114	-
S&GA Expenses	4.6%	47.00	45.00	50.00	48.00	37.00	41.00	43.00	41.00	35.00	33.00	43.00	57.00	32.00	26.00	17.00	14.00	25.00	12.00	6.00	13.00	17.00
EBITDA Margin	-388.9%	-0.07*	0.02*	0.19*	0.18*	0.19*	0.19*	0.21*	0.24*	0.22*	0.17*	0.09*	0.01*	-0.08*	-	-	-	-	-	-	-	-
Interest Expenses	3.7%	33.00	32.00	33.00	32.00	31.00	29.00	26.00	25.00	26.00	24.00	23.00	22.00	14.00	12.00	7.00	8.00	8.00	11.00	15.00	6.00	-
Income Taxes	47.6%	-18.12	-34.58	5.00	-1.70	5.00	6.00	9.00	6.00	10.00	12.00	12.00	-1.69	-7.23	-4.90	2.00	-1.64	-4.67	1.00	2.00	2.00	-2.64
Earnings Before Taxes	44.3%	-271	-487	20.00	15.00	3.00	23.00	24.00	48.00	33.00	70.00	92.00	-5.34	-97.73	-66.90	10.00	-51.09	-17.07	-2.03	0.00	-3.03	20.00
EBT Margin	-57.3%	-0.23*	-0.14*	0.02*	0.02*	0.03*	0.04*	0.06*	0.09*	0.08*	0.03*	-0.04*	-0.12*	-0.20*	-	-	-	-	-	-	-	-
Net Income	43.7%	-255	-454	15.00	17.00	-3.44	16.00	15.00	42.00	22.00	58.00	80.00	-3.64	-74.76	-51.03	8.00	-49.45	-10.13	-3.69	-1.72	-5.45	22.00
Net Income Margin	-55.3%	-0.21*	-0.14*	0.01*	0.01*	0.02*	0.03*	0.05*	0.08*	0.06*	0.03*	-0.03*	-0.09*	-0.16*	-	-	-	-	-	-	-	-
Free Cashflow	206.3%	67.00	22.00	4.00	51.00	-45.99	13.00	26.00	-10.71	37.00	-33.16	85.00	-17.22	33.00	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-4.6%	4,509	4,725	5,203	5,283	5,220	5,238	5,202	5,204	5,250	5,192	4,688	4,520	1,813	1,556	742	665	547	257	256	255	369
Current Assets	10.9%	649	585	568	647	585	632	605	615	670	823	591	504	363	484	264	195	181	1.00	1.00	1.00	91.00
Cash Equivalents	37.4%	77.00	56.00	45.00	101	46.00	111	119	119	150	337	178	132	100	272	111	48.00	77.00	9.00	2.00	15.00	25.00
Inventory	-2.3%	114	116	115	136	128	125	103	100	123	100	82.00	75.00	59.00	46.00	24.00	18.00	13.00	-	-	-	8.00
Net PPE	-	-	-	-	-	-	473	455	425	399	341	309	299	110	102	83.00	87.00	64.00	-	-	-	62.00
Goodwill	-10.4%	2,725	3,041	3,552	3,545	3,545	12.00	5.00	2.00	3,513	29.00	46.00	40.00	999	36.00	50.00	1.00	267	44.00	14.00	-	-
Liabilities	1.9%	3,042	2,985	3,016	3,116	3,062	3,078	3,064	3,084	3,184	3,197	2,794	2,728	1,533	1,211	814	765	612	411	210	9.00	266
Current Liabilities	19.8%	537	448	458	524	456	467	435	444	500	502	606	513	422	315	257	191	154	3.00	2.00	1.00	136
Long Term Debt	-1.5%	2,095	2,127	2,136	2,169	2,153	2,162	2,171	2,180	2,184	2,187	1,776	1,749	777	723	443	464	395	-	-	-	127
LT Debt, Current	33.4%	53.00	40.00	40.00	40.00	35.00	30.00	25.00	20.00	20.00	20.00	97.00	18.00	8.00	8.00	3.00	3.00	2.00	-	-	-	7.00
LT Debt, Non Current	-1.5%	2,095	2,127	2,136	2,169	2,153	2,162	2,171	2,180	2,184	2,187	1,776	1,749	777	723	443	464	395	-	-	-	127
Shareholder's Equity	-15.8%	1,458	1,732	2,187	2,167	2,151	2,160	2,138	2,121	2,067	1,994	1,894	1,792	281	315	8.00	-	-	5.00	5.00	5.00	5.00
Retained Earnings	-63.9%	-652	-398	56.00	42.00	26.00	29.00	13.00	-1.27	-43.02	-65.96	-124	-203	-199	-118	-70.34	-74.81	-40.26	2.00	2.00	3.00	-13.37
Additional Paid-In Capital	0.2%	2,150	2,145	2,140	2,135	2,130	2,126	2,119	2,113	2,107	2,057	2,016	1,994	558	485	17.00	26.00	4.00	3.00	3.00	2.00	3.00
Shares Outstanding	-1.7%	133	135	135	134	134	134	134	134	126	124	120	111	52.00	-	-	-	-	-	-	-	-
Minority Interest	12.7%	8.00	7.00	6.00	8.00	7.00	6.00	4.00	5.00	5.00	4.00	4.00	4.00	-74.04	-45.83	-42.59	-46.35	-26.96	-	-	-	-
Float	-	-	-	1,260	-	-	-	1,510	-	-	-	2,170	-	-	-	185	-	-	-	253	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	57.1%	155	99.00	86.00	140	97.00	107	103	66.00	101	27.00	129	18.00	50.00	34.00	87.00	24.00	17.00	17.00	10.00	16.00	70.00
Share Based Compensation	14.7%	5.00	5.00	7.00	6.00	6.00	6.00	6.00	6.00	4.00	5.00	7.00	9.00	8.00	6.00	3.00	2.00	5.00	0.00	0.00	5.00	-
Cashflow From Investing	-17.3%	-90.42	-77.10	-100	-89.57	-145	-95.34	-89.93	-80.10	-266	-186	-158	-1,213	-188	-509	-6.00	-111	-22.47	-23.69	-12.53	-26.18	153
Cashflow From Financing	-309.2%	-43.86	-10.72	-42.40	4.00	-15.59	-19.75	-14.16	-16.55	-21.71	318	75.00	1,228	-34.10	637	-18.20	58.00	73.00	13.00	-9.98	-0.37	-202
Buy Backs	-	20.00	-	-	9.00	-	11.00	3.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-

AHCO Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net revenue	$ 3,200,177	$ 2,970,595	$ 2,454,535
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Grant income	$ 0	$ 0	$ 10,595
Costs and expenses:
Cost of net revenue	$ 2,720,613	$ 2,553,169	$ 2,008,925
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 190,091	$ 162,125	$ 167,505
Depreciation and amortization, excluding patient equipment depreciation	57,087	64,890	63,095
Goodwill impairment (note 5)	830,787	0	0
Total costs and expenses	3,798,578	2,780,184	2,239,525
Operating (loss) income	(598,401)	190,411	225,605
Interest expense, net	130,299	109,414	95,195
Change in fair value of warrant liability (note 11)	(34,482)	(17,158)	(53,181)
Change in fair value of contingent consideration common shares liability (note 11)	0	0	(29,389)
Loss on extinguishment of debt	0	0	20,189
Other loss, net	29,566	253	1,832
(Loss) income before income taxes	(723,784)	97,902	190,959
Income tax (benefit) expense	(49,004)	24,769	32,806
Net (loss) income	(674,780)	73,133	158,153
Income attributable to noncontrolling interest	4,115	3,817	1,978
Net (loss) income attributable to AdaptHealth Corp.	$ (678,895)	$ 69,316	$ 156,175
Weighted average common shares outstanding - basic (in shares)	134,156	134,175	126,306
Weighted average common shares outstanding - diluted (in shares)	134,418	138,988	133,034
Basic net income (loss) per share (note 12) (in dollars per share)	$ (5.06)	$ 0.47	$ 1.12
Diluted net income (loss) per share (note 12) (in dollars per share)	$ (5.31)	$ 0.33	$ 0.67

AHCO Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 77,132	$ 46,272
Accounts receivable	388,910	359,146
Inventory	113,642	127,754
Prepaid and other current assets	69,338	52,136
Total current assets	649,022	585,308
Equipment and other fixed assets, net	495,101	487,079
Operating lease right-of-use assets	110,465	129,506
Finance lease right-of-use assets	31,962	5,423
Goodwill	2,724,958	3,545,297
Identifiable intangible assets, net	130,160	162,773
Other assets	21,128	22,415
Deferred tax assets	345,854	281,786
Total Assets	4,508,650	5,219,587
Current liabilities:
Accounts payable and accrued expenses	391,994	337,498
Current portion of long-term debt	53,368	35,000
Current portion of operating lease obligations	29,270	30,001
Current portion of finance lease obligations	9,122	2,211
Contract liabilities	38,570	31,641
Warrant liability	4,021	0
Other liabilities	10,654	19,863
Total current liabilities	536,999	456,214
Long-term debt, less current portion	2,094,614	2,153,267
Operating lease obligations, less current portion	85,529	104,394
Finance lease obligations, less current portion	22,746	3,950
Other long-term liabilities	302,093	305,501
Warrant liability	0	38,503
Total Liabilities	3,041,981	3,061,829
Commitments and contingencies (Note 16)
Stockholders' Equity:
Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized and 132,634,850 and 134,435,119 shares issued and outstanding as of December 31, 2023 and 2022, respectively	13	13
Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of December 31, 2023 and 2022	1	1
Treasury stock, at cost (3,935,035 and 750,835 shares as of December 31, 2023 and 2022, respectively)	(43,267)	(13,992)
Additional paid-in capital	2,149,951	2,130,148
(Accumulated deficit) Retained earnings	(652,600)	26,295
Accumulated other comprehensive income	4,356	8,693
Total stockholders' equity attributable to AdaptHealth Corp.	1,458,454	2,151,158
Noncontrolling interest in subsidiary	8,215	6,600
Total Stockholders' Equity	1,466,669	2,157,758
Total Liabilities and Stockholders' Equity	$ 4,508,650	$ 5,219,587

About AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

WEBSITE	https://adapthealth.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	10900

AdaptHealth Corp Frequently Asked Questions

What is the ticker symbol for AdaptHealth Corp? What does AHCO stand for in stocks?

AHCO is the stock ticker symbol of AdaptHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AdaptHealth Corp (AHCO)?

As of Thu Apr 18 2024, market cap of AdaptHealth Corp is 1.25 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers. The fair value of AdaptHealth Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of AdaptHealth Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AHCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is AdaptHealth Corp a good stock to buy?

The fair value guage provides a quick view whether AHCO is over valued or under valued. Whether AdaptHealth Corp is cheap or expensive depends on the assumptions which impact AdaptHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AHCO.

What is AdaptHealth Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, AHCO's PE ratio (Price to Earnings) is -1.84 and Price to Sales (PS) ratio is 0.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AHCO PE ratio will change depending on the future growth rate expectations of investors.